Microbiota transplantation in animal models, or selective inhibition of NLRP3, reduced the fibrosis process and the arrhythmia susceptibility, underlining the role of systemic inflammation related to dysbiosis as a pathogenetic element of atrial fibrillation [10,11,12]. Here, NLRP3 is linked to atrial fibrillation.